A protocol for designing siRNAs with high functionality and specificity
- PMID: 17853862
- DOI: 10.1038/nprot.2007.278
A protocol for designing siRNAs with high functionality and specificity
Abstract
Effective gene silencing by the RNA interference (RNAi) pathway requires a comprehensive understanding of the elements that influence small interfering RNA (siRNA) functionality and specificity. These include (i) sequence space restrictions that define the boundaries of siRNA targeting, (ii) structural and sequence features required for efficient siRNA performance, (iii) mechanisms that underlie nonspecific gene modulation and (iv) additional features specific to the intended use (i.e., inclusion of native sugar or base chemical modifications for increased stability or specificity, vector design, etc.). Attention to each of these factors enhances siRNA performance and heightens overall confidence in the output of RNAi-mediated functional genomic studies. Here, we provide a detailed protocol explaining the methodologies used for manual and web-based design of siRNAs.
Similar articles
-
siVirus: web-based antiviral siRNA design software for highly divergent viral sequences.Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W448-50. doi: 10.1093/nar/gkl214. Nucleic Acids Res. 2006. PMID: 16845046 Free PMC article.
-
The impact of target site accessibility on the design of effective siRNAs.Nat Biotechnol. 2008 May;26(5):578-83. doi: 10.1038/nbt1404. Epub 2008 Apr 27. Nat Biotechnol. 2008. PMID: 18438400
-
RFRCDB-siRNA: improved design of siRNAs by random forest regression model coupled with database searching.Comput Methods Programs Biomed. 2007 Sep;87(3):230-8. doi: 10.1016/j.cmpb.2007.06.001. Epub 2007 Jul 17. Comput Methods Programs Biomed. 2007. PMID: 17644215
-
In silico selection of active siRNA.Drug Discov Today. 2007 Feb;12(3-4):139-48. doi: 10.1016/j.drudis.2006.11.015. Epub 2006 Dec 13. Drug Discov Today. 2007. PMID: 17275734 Review.
-
siRNAs: their potential as therapeutic agents--Part I. Designing of siRNAs.Drug Discov Today. 2009 Sep;14(17-18):851-8. doi: 10.1016/j.drudis.2009.06.001. Epub 2009 Jun 21. Drug Discov Today. 2009. PMID: 19540928 Review.
Cited by
-
Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges.Front Mol Biosci. 2024 Sep 17;11:1447953. doi: 10.3389/fmolb.2024.1447953. eCollection 2024. Front Mol Biosci. 2024. PMID: 39355533 Free PMC article. Review.
-
Nuclear Phosphoproteomic Screen Uncovers ACLY as Mediator of IL-2-induced Proliferation of CD4+ T lymphocytes.Mol Cell Proteomics. 2016 Jun;15(6):2076-92. doi: 10.1074/mcp.M115.057158. Epub 2016 Apr 11. Mol Cell Proteomics. 2016. PMID: 27067055 Free PMC article.
-
Improved siRNA/shRNA functionality by mismatched duplex.PLoS One. 2011;6(12):e28580. doi: 10.1371/journal.pone.0028580. Epub 2011 Dec 9. PLoS One. 2011. PMID: 22174840 Free PMC article.
-
Editorial focus: understanding off-target effects as the key to successful RNAi therapy.Cell Mol Biol Lett. 2019 Dec 9;24:69. doi: 10.1186/s11658-019-0196-3. eCollection 2019. Cell Mol Biol Lett. 2019. PMID: 31867046 Free PMC article. Review.
-
Gene Therapy for Rhodopsin Mutations.Cold Spring Harb Perspect Med. 2022 Aug 8;12(9):a041283. doi: 10.1101/cshperspect.a041283. Online ahead of print. Cold Spring Harb Perspect Med. 2022. PMID: 35940643 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources